Resources & Budgeting: Overview and Instructions for Afternoon Sessions

1. Resources & Budgeting: Overview and Instructions for Afternoon Sessions Kimberly Rogers Wyoming Department of Health Comprehensive Cancer Control 6101 Yellowstone Rd, Suite 259A Cheyenne, WY 82002

2. Now and Then: Price Comparison

3. Reducing Workplace Costs in Harsh Economic Times

4. Background & History • National Cancer Act of 1971 • "I will also ask for an appropriation of an extra $100 million to launch an intensive campaign to find a cure for cancer, and I will ask later for whatever additional funds can effectively be used. The time has come in America when the same kind of concentrated effort that split the atom and took man to the moon should be turned toward conquering this dread disease. Let us make a total national commitment to achieve this goal." – Richard Nixon • 1971 budget from $150 to $220 million.

5. Cost of Cancer - 2000 Overall costs for cancer in the year 2000 was $180.2 billion: $60 billion for direct medical costs (total of all health expenditures); $15 billion for indirect morbidity costs (cost of lost productivity due to illness); and $105.2 billion for indirect mortality costs (cost of lost productivity due to premature death). Cancer-related costs account for about 10 percent of the total amount spent on disease treatment in the United States. Cancer is a major national burden. National Institutes of Health, 2000

6. Cost of Cancer Treatment- 1963-2004Direct Medical Costs Only Source: Cancer Trends Progress Report 2007 Update (National Cancer Institute)

7. Cancer Research Spending NCI Spending in FY 2005, 2006, and 2007 for the 10 most common types of cancer in the United States (excluding basal cell and squamous cell skin cancers). NCI Office of Budget & Finance

8. “Money was never a big motivation for me, except as a way to keep score. The real excitement is playing the game” ~Donald Trump

9. Let’s Get Ready to Rumble!: Creating A Business Case for Cancer Control • Evidence why your project makes solid financial sense to the agency/ organization; • Supports planning and decision-making, such as how much to invest in the project, what agency/entity can implement your project, and when to begin implementation; and • Maximizing the value created by the effort.

10. Why a Business Case? • Show the need to continue Comprehensive Cancer Control Programs within our states, tribes, and territories; • Reducing costs of treatment via early detection; • Ensuring no duplication of services or efforts; • Evidencing health outcomes tied to changes in practice, policy and/or procedure. • Evidence financial benefits to having CCC; and • Provide a need for additional legislation and/or policy to support CCC efforts.

11. Wyoming Example (DRAFT) Year 1 Cost Benefit to the State of Wyoming: Analysis of Patients Diagnosed with Pre-Cancer or Cancer of the Colon (November 16, 2007- February 10, 2009)

12. Cost of Colorectal Cancer Early Stage: Individual treatment costs for Colorectal Cancer is estimated at approximately $30,000 per patient Late Stage: Individual treatment costs for Colorectal Cancer is estimated at approximately $120,000 per patient

13. Uncompensated Healthcare Costs • Most uncompensated healthcare dollars are incurred by hospitals, where services are most costly. • In 2001, hospitals accounted for over 60% of uncompensated healthcare dollars! • The primary source of funding for uncompensated care is government dollars! • In 2004, 85% of total uncompensated healthcare costs were covered by government entities. Kaiser Commission on Medicaid and the Uninsured, The Cost of Care for the Uninsured: What Do We Spend, Who Pays, and What Would Full Coverage Add to Medical Spending?, Issue Update, 2004

14. Wyoming $ and ¢ Potential cost to the State of Wyoming to TREAT cancers Cost to screen these 117 patients was $228,150.

15. Steps to Creating Our Business Case • Developed a CCC Plan Budget; • Engaged Policymakers in our cancer control financial agenda; • 2007 Wyoming Cancer Control Act (EA92) • Implemented our programs via the Wyoming Cancer Control Act; • Completed Cost Benefit Analysis; and • In 2010 budget session, the analysis will be expanded and shared with the 60th WSL.

16. What’s Ahead? • Afternoon Sessions • Resources and Budgeting roundtables by TOPIC • Maplewood A: Purpose and Uses for Developing a CCC Plan Budget- Funding your Plan! • Maplewood B: Engaging Policymakers in Your CCC Financial Agenda • Camellia: CCC Program Budget Development in Harsh Economic Times • Ravinia ABC: Cost Benefit to CCC: Are We Making A Difference?

17. Regional Roundtable Sessions Maplewood A: Kim Rogers/Room Monitor Stacy Lofton/Garry Lowry Mary Boyd Susan White

18. Regional Roundtable Sessions Maplewood B: Peg Knight/Room Monitor Vicki D’Alfonso/ Jamila Fonseka Dana White Ann Larkin

19. Regional Roundtable Sessions Camellia: June Ryan/Room Monitor Ann Major/Angela Moore Annette Gardner

20. Regional Roundtable Sessions Ravinia ABC: Melody Robinson/Room Monitor Barbara Wethers/ Susan Derrick Tina Gill

21. Note: • If you feel you’ve been misplaced in an inappropriate group, please feel free to move to a more appropriate group based on demographics and population. We tried to stick to CDC project offer assignments in relation to regions.

22. Ralph Waldo Emerson “Our best thoughts come from others….”

23. Contact Information Kimberly Rogers Wyoming Department of Health Comprehensive Cancer Control 6101 Yellowstone Rd, Suite 259A Cheyenne, WY 82002 (307) 777-8609 Kimberly.Rogers@Health.Wyo.Gov